Multifocal acceptance score to evaluate vision: MAS-2EV.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 01 2021
14 01 2021
Historique:
received:
29
04
2020
accepted:
04
01
2021
entrez:
15
1
2021
pubmed:
16
1
2021
medline:
16
1
2021
Statut:
epublish
Résumé
We present a new metric (Multifocal Acceptance Score, MAS-2EV) to evaluate vision with presbyopic corrections. The MAS-2EV is based on a set of images representing natural visual scenes at day and night conditions projected in far and near displays, and a near stereo target. Subjects view and score the images through different binocular corrections (monofocal corrections at far; bifocal corrections; monovision and modified monovision) administered with soft contact lenses (in cyclopleged young subjects) or with a binocular simultaneous vision simulator (in presbyopic and cyclopleged young subjects). MAS-2EV scores are visually represented in the form of polygons, and quantified using different metrics: overall visual quality, visual degradation at far, visual benefit at near, near stereo benefit, visual imbalance near-far, overall visual imbalance and a combined overall performance metric. We have found that the MAS-2EV has sufficient repeatability and sensitivity to allow differentiation across corrections with only two repetitions, and the duration of the psychophysical task (3 min for subject/condition/correction) makes it useable in the clinic. We found that in most subjects binocular bifocal corrections produce the lowest visual imbalance, and the highest near stereo benefit. 46.67% of the subjects ranked binocular bifocal corrections first, and 46.67% of the subjects ranked monovision first. MAS-2EV, particularly in combination with visual simulators, can be applied to select prospective presbyopic corrections in patients prior to contact lens fitting or intraocular lens implantation.
Identifiants
pubmed: 33446794
doi: 10.1038/s41598-021-81059-0
pii: 10.1038/s41598-021-81059-0
pmc: PMC7809428
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1397Références
PLoS One. 2014 Mar 24;9(3):e93089
pubmed: 24664087
Ophthalmic Physiol Opt. 2007 Sep;27(5):417-39
pubmed: 17718882
Optom Vis Sci. 2016 Aug;93(8):801-8
pubmed: 27383257
Sci Rep. 2019 Feb 7;9(1):1539
pubmed: 30733540
J Cataract Refract Surg. 2009 Mar;35(3):504-13
pubmed: 19251145
Biomed Opt Express. 2018 Nov 15;9(12):6302-6317
pubmed: 31065430
Ophthalmic Physiol Opt. 2014 Jan;34(1):8-29
pubmed: 24205890
J Cataract Refract Surg. 2012 Oct;38(10):1724-33
pubmed: 22902188
Opt Express. 2007 Nov 26;15(24):16177-88
pubmed: 19550905
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5537-45
pubmed: 20505205
J Cataract Refract Surg. 2018 Feb;44(2):156-167
pubmed: 29587972
Ophthalmology. 2003 Dec;110(12):2292-301
pubmed: 14644710
Biomed Opt Express. 2017 Jun 23;8(7):3410-3425
pubmed: 28717577
Clin Exp Optom. 2008 May;91(3):207-25
pubmed: 18336584
Vision Res. 2017 Mar;132:85-96
pubmed: 27484778
Opt Express. 2019 Feb 4;27(3):2085-2100
pubmed: 30732252
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1091-1099
pubmed: 30824995
J Cataract Refract Surg. 2013 Mar;39(3):343-9
pubmed: 23332118
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5685-94
pubmed: 21676909
Biomed Opt Express. 2017 Mar 03;8(4):2055-2068
pubmed: 28736655
Clin Exp Optom. 2017 Mar;100(2):107-127
pubmed: 27800638
Optom Vis Sci. 2017 Feb;94(2):183-196
pubmed: 27748699
Optom Vis Sci. 2016 Apr;93(4):344-52
pubmed: 26784710
Eur J Ophthalmol. 2012 Mar-Apr;22(2):175-87
pubmed: 21623590
Biomed Opt Express. 2019 Oct 21;10(11):5801-5817
pubmed: 31799048
Ophthalmic Physiol Opt. 2014 Jul;34(4):397-426
pubmed: 24716827